> Detailanzeige

Rühle, Alexander [VerfasserIn]; Haehl, Erik [VerfasserIn]; Kalckreuth, Tobias von [VerfasserIn]; Stoian, Raluca [VerfasserIn]; Spohn, Simon Konrad Benedict [VerfasserIn]; Sprave, Tetyana [VerfasserIn]; Zamboglou, Constantinos [VerfasserIn]; Gkika, Eleni [VerfasserIn]; Knopf, Andreas [VerfasserIn]; Grosu, Anca-Ligia [VerfasserIn]; Nicolay, Nils [VerfasserIn]

Surviving elderly patients with head-and-neck squamous cell carcinoma - what is the long-term quality of life after curative radiotherapy?

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Book; Sonderdruck
  • Titel: Surviving elderly patients with head-and-neck squamous cell carcinoma - what is the long-term quality of life after curative radiotherapy?
  • Beteiligte: Rühle, Alexander [VerfasserIn]; Haehl, Erik [VerfasserIn]; Kalckreuth, Tobias von [VerfasserIn]; Stoian, Raluca [VerfasserIn]; Spohn, Simon Konrad Benedict [VerfasserIn]; Sprave, Tetyana [VerfasserIn]; Zamboglou, Constantinos [VerfasserIn]; Gkika, Eleni [VerfasserIn]; Knopf, Andreas [VerfasserIn]; Grosu, Anca-Ligia [VerfasserIn]; Nicolay, Nils [VerfasserIn]
  • Erschienen: Basel: MDPI, 2021
  • Erschienen in: Cancers ; 13, 6 (2021), 1275
  • Umfang: 1 Online-Ressource (14 Seiten); Diagramme
  • Sprache: Englisch
  • DOI: 10.3390/cancers13061275
  • ISSN: 2072-6694
  • Identifikator:
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Abstract: The effects of radiotherapy on the long-term quality of life (QoL) of surviving elderly HNSCC patients are not well understood, therefore, we analyzed QoL in this population. A cross-sectional analysis was performed at a tertiary cancer center to assess long-term QoL in elderly HNSCC patients. Eligible patients were ≥65 years at the time of treatment who had to be alive for ≥1 year after radiotherapy and without current anti-cancer treatment. QoL and patient satisfaction were assessed using the EORTC QLQ-C30, QLQ-H&N35 and ZUF-8 questionnaires, respectively, and treatment-related toxicities were graded according to CTCAE (Common Terminology Criteria of Adverse Effects) v.5.0. Seventy-four patients met the inclusion criteria, of which 50 consented to participate. Median time between radiotherapy and QoL assessment was 32 months (range 12–113). The QLQ-C30 global QoL median amounted to 66.7 points (interquartile range (IQR) 50.0–83.3), which was comparable to the age- and gender-adjusted German population (median 65.3). Median global QoL was similar between patients undergoing definitive (75.0, IQR 50.0–83.3) and adjuvant (chemo)radiotherapy (66.7, IQR 41.7–83.3, p = 0.219). HPV-positive HNSCC patients had superior global QoL after radiotherapy than their HPV-negative counterparts (p < 0.05), and concomitant chemotherapy did not influence the long-term QoL (p = 0.966). Median global QoL did not correspond with physician-assessed highest-graded chronic toxicities (p = 0.640). The ZUF-8 ranged at 29 points in median (IQR 27–31), showing high patient satisfaction. Surviving elderly HNSCC patients treated by radiotherapy exhibit a relatively high long-term global QoL which is a relevant information for clinicians treating elderly HNSCC patients
  • Zugangsstatus: Freier Zugang